Literature DB >> 16625261

Retinal prostheses for the blind.

Michael Javaheri1, David S Hahn, Rohit R Lakhanpal, James D Weiland, Mark S Humayun.   

Abstract

INTRODUCTION: Using artificial means to treat extreme vision impairment has come closer to reality during the past few decades. The goal of this research has been to create an implantable medical device that provides useful vision for those patients who are left with no alternatives. Analogous to the cochlear implants for some forms of hearing loss, these devices could restore useful vision by converting visual information into patterns of electrical stimulation that excite the remaining viable inner retinal neurons in patients with retinitis pigmentosa or age-related macular degeneration.
METHODS: Data for this review were selected through a comprehensive literature search.
RESULTS: Advances in microtechnology have facilitated the development of a variety of prostheses that can be implanted in the visual cortex, around the optic nerve, or in the eye. Some of these approaches have shown the promise of providing useful visual input to patients with visual impairments.
CONCLUSION: While the development of various retinal prostheses have shown promise in limited clinical trials, there are distinct advantages and disadvantages for each type of prosthesis. This review will focus primarily on the Epiretinal Intraocular Retinal Prosthesis, studied by our group, but will also briefly review other modalities: the subretinal prosthesis, cortical prosthesis, and optic nerve prosthesis.

Entities:  

Mesh:

Year:  2006        PMID: 16625261

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  11 in total

Review 1.  Channelrhodopsins provide a breakthrough insight into strategies for curing blindness.

Authors:  Hiroshi Tomita; Eriko Sugano; Hitomi Isago; Makoto Tamai
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

2.  High-resolution electrical stimulation of primate retina for epiretinal implant design.

Authors:  Chris Sekirnjak; Pawel Hottowy; Alexander Sher; Wladyslaw Dabrowski; Alan M Litke; E J Chichilnisky
Journal:  J Neurosci       Date:  2008-04-23       Impact factor: 6.167

3.  [Development of a minimally invasive retinal implant system].

Authors:  H Gerding
Journal:  Ophthalmologe       Date:  2008-05       Impact factor: 1.059

Review 4.  Role of electrical activity in promoting neural repair.

Authors:  Jeffrey L Goldberg
Journal:  Neurosci Lett       Date:  2012-02-10       Impact factor: 3.046

Review 5.  Building the bionic eye: an emerging reality and opportunity.

Authors:  Lotfi B Merabet
Journal:  Prog Brain Res       Date:  2011       Impact factor: 2.453

6.  Changes in physiological properties of rat ganglion cells during retinal degeneration.

Authors:  Chris Sekirnjak; Lauren H Jepson; Pawel Hottowy; Alexander Sher; Wladyslaw Dabrowski; A M Litke; E J Chichilnisky
Journal:  J Neurophysiol       Date:  2011-03-09       Impact factor: 2.714

7.  Immunocytochemical analysis of retinal neurons under electrical stimulation.

Authors:  Aditi Ray; Leonardo Colodetti; James D Weiland; David R Hinton; Mark S Humayun; Eun-Jin Lee
Journal:  Brain Res       Date:  2008-12-09       Impact factor: 3.252

Review 8.  Brain-computer interfaces: a powerful tool for scientific inquiry.

Authors:  Jeremiah D Wander; Rajesh P N Rao
Journal:  Curr Opin Neurobiol       Date:  2013-12-27       Impact factor: 6.627

9.  Loss of responses to visual but not electrical stimulation in ganglion cells of rats with severe photoreceptor degeneration.

Authors:  Chris Sekirnjak; Clare Hulse; Lauren H Jepson; Pawel Hottowy; Alexander Sher; Wladyslaw Dabrowski; A M Litke; E J Chichilnisky
Journal:  J Neurophysiol       Date:  2009-09-02       Impact factor: 2.714

10.  Electrophysiology Alterations in Primary Visual Cortex Neurons of Retinal Degeneration (S334ter-line-3) Rats.

Authors:  Ke Chen; Yi Wang; Xiaohua Liang; Yihuai Zhang; Tsz Kin Ng; Leanne Lai Hang Chan
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.